Event Data
{"article_title":"Clinical guidelines for primary sclerosing cholangitis 2017.","author":"Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H","journal_title":"Journal of gastroenterology","issn":"1435-5922","isbn":"","publication_date":"2018-09-01","volume":"53","issue":"9","first_page":"1006","page_count":"","accession_number":"29951926","doi":"","publisher":"Springer International","doctype":"Journal Article","subjects":"Japan; Cholangitis, Sclerosing epidemiology; Cholangitis, Sclerosing physiopathology; Rare Diseases epidemiology; Rare Diseases physiopathology; Adult; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing diagnosis; Cholangitis, Sclerosing therapy; Diagnosis, Differential; Endosonography; Female; Humans; Japan epidemiology; Liver Transplantation; Male; Middle Aged; Prognosis; Rare Diseases diagnosis; Rare Diseases therapy","interest_area":["Gastroenterology"],"abstract":"Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC. Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA. Results: We had made 16 guidelines about epidemiology\/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart. Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=29951926","isPdfLink":true,"isSAML":false,"an":"29951926","number_other":"","type_pub":"","issn_electronic":"1435-5922","languages":"English","language":"eng","date_entry":"","date_update":"","titleSource":"Journal of gastroenterology [J Gastroenterol] 2018 Sep; Vol. 53 (9), pp. 1006-1034. Date of Electronic Publication: 2018 Jun 27.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2018-09-01","description":"Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC.<br \/>Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA.<br \/>Results: We had made 16 guidelines about epidemiology\/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart.<br \/>Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=29951926&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H","header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"29951926","RelevancyScore":"844","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"844.011901855469"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=29951926&authtype=shib&custid=ns346513&group=main&profile=eds","physicalDescription":{"Pagination":{"StartPage":"1006"}},"additionalInfo":{"Authored_By":"Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H","Corporate_Authors":"PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group","Journal_Info":"Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2018-09-01","Source":"Journal of gastroenterology [J Gastroenterol] 2018 Sep; Vol. 53 (9), pp. 1006-1034. Date of Electronic Publication: 2018 Jun 27.","Languages":"English","Electronic_ISSN":"1435-5922","MeSH_Terms":"Cholangitis, Sclerosing\/*epidemiology , Cholangitis, Sclerosing\/*physiopathology , Rare Diseases\/*epidemiology , Rare Diseases\/*physiopathology, Adult ; Biopsy ; Cholangiopancreatography, Endoscopic Retrograde ; Cholangitis, Sclerosing\/diagnosis ; Cholangitis, Sclerosing\/therapy ; Diagnosis, Differential ; Endosonography ; Female ; Humans ; Japan\/epidemiology ; Liver Transplantation ; Male ; Middle Aged ; Prognosis ; Rare Diseases\/diagnosis ; Rare Diseases\/therapy","Subjects":"Adult, Biopsy, Cholangiopancreatography, Endoscopic Retrograde, Cholangitis, Sclerosing diagnosis, Cholangitis, Sclerosing therapy, Diagnosis, Differential, Endosonography, Female, Humans, Japan epidemiology, Liver Transplantation, Male, Middle Aged, Prognosis, Rare Diseases diagnosis, Rare Diseases therapy, Cholangitis, Sclerosing epidemiology, Cholangitis, Sclerosing physiopathology, Rare Diseases epidemiology, Rare Diseases physiopathology","Title_Abbreviations":"Journal of gastroenterology","Volume":"53"}}
Additional Info
["Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H","PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group","Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE","Journal Article; Practice Guideline","2018-09-01","Journal of gastroenterology [J Gastroenterol] 2018 Sep; Vol. 53 (9), pp. 1006-1034. Date of Electronic Publication: 2018 Jun 27.","English","1435-5922","Cholangitis, Sclerosing\/*epidemiology , Cholangitis, Sclerosing\/*physiopathology , Rare Diseases\/*epidemiology , Rare Diseases\/*physiopathology, Adult ; Biopsy ; Cholangiopancreatography, Endoscopic Retrograde ; Cholangitis, Sclerosing\/diagnosis ; Cholangitis, Sclerosing\/therapy ; Diagnosis, Differential ; Endosonography ; Female ; Humans ; Japan\/epidemiology ; Liver Transplantation ; Male ; Middle Aged ; Prognosis ; Rare Diseases\/diagnosis ; Rare Diseases\/therapy","Adult, Biopsy, Cholangiopancreatography, Endoscopic Retrograde, Cholangitis, Sclerosing diagnosis, Cholangitis, Sclerosing therapy, Diagnosis, Differential, Endosonography, Female, Humans, Japan epidemiology, Liver Transplantation, Male, Middle Aged, Prognosis, Rare Diseases diagnosis, Rare Diseases therapy, Cholangitis, Sclerosing epidemiology, Cholangitis, Sclerosing physiopathology, Rare Diseases epidemiology, Rare Diseases physiopathology","Journal of gastroenterology","53"]
Description
Background: Primary sclerosing cholangitis (PSC) is relatively rare disease and pathogenesis and methods of treatments were still not established. Then, we had conducted the making clinical guidelines to manage patients with PSC based on the literature review and expert opinions. These clinical guidelines were made for the medical doctors on the management of PSC, except child case of PSC.
Methods: We had employed modified Delphi method. The production committee decided guidelines, strength of recommendations and evidence level after reviewed literatures systematically, and The Expert panel evaluated those. The Scientific Committee of the Japan Biliary Association (JBA) evaluated revised guidelines, and the Public comments were collected on web site of JBA.
Results: We had made 16 guidelines about epidemiology/pathophysiology, diagnostics, therapy and prognosis. Also, we had made both diagnostic and therapeutic flow chart.
Conclusions: We hope that these guidelines will contribute to the improvement and development of the medical care of PSC.
